Showing results (171-180 of 195) with videos related to
Sort By:
Pageof 20
Plos One|May 2, 2024
Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in IndiaSuman Kanungo, Uttaran Bhattacharjee, Aslesh O Prabhakaran, et al.Scientific Reports|November 21, 2025
Spinal cord neuromodulation for blood pressure control using low-intensity focused ultrasoundAngelica F Lopez, Denis Routkevitch, Patrick J Kramer, et al.Operative Neurosurgery (Hagerstown, Md.)|November 13, 2025
Robot-Assisted Pedicle Screw Insertion in Pediatric Spine Surgery: An Institutional Experience and Meta-AnalysisTaha Khalilullah, Abdul Karim Ghaith, Xinlan Yang, et al.The American Journal of Gastroenterology|January 6, 2016
Prevalence of Adult Celiac Disease in India: Regional Variations and AssociationsB S Ramakrishna, Govind K Makharia, Kamal Chetri, et al.BMJ Public Health|December 20, 2023
Cost of acute respiratory illness episode and its determinants among community-dwelling older adults: a four-site cohort study from IndiaAnand Krishnan, Kusum Shekhawat, Ismael R Ortega-Sanchez, et al.Journal of the American College of Cardiology|March 4, 2022
Trends in Utilization of Aortic Valve Replacement for Severe Aortic StenosisShawn X Li, Nilay K Patel, Laura D Flannery, et al.BMJ Public Health|July 7, 2025
Resource utilisation and cost of hospitalisation with community-acquired pneumonia among older adults in India, 2018-2020Aslesh Ottapura Prabhakaran, Ritvik Amarchand, Suman Kanungo, et al.Iscience|April 25, 2023
Toward a roadmap for space-based observations of the land sector for the UNFCCC global stocktakeOsamu Ochiai, Benjamin Poulter, Frank Martin Seifert, et al.Influenza and Other Respiratory Viruses|April 30, 2026
Burden of Influenza and Cost-Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in IndiaAnand Krishnan, Aslesh Ottapura Prabhakaran, Kusum Shekhawat, et al.Scientific Reports|December 18, 2025
Virus-derived serpin reduces immuno-coagulopathic damage in murine colitis by targeting the urokinase-type plasminogen activator receptor (uPAR) and complementAlexandra R Lucas, Henna Monder, Junior Enow, et al.Pageof 20